Washington Capital Management Inc. Acquires New Holdings in Humana Inc. (NYSE:HUM)

Washington Capital Management Inc. bought a new position in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,700 shares of the insurance provider’s stock, valued at approximately $431,000.

A number of other institutional investors have also made changes to their positions in the stock. State Street Corp boosted its position in shares of Humana by 1.0% during the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock worth $1,701,582,000 after purchasing an additional 53,272 shares during the period. FMR LLC lifted its stake in Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after purchasing an additional 643,291 shares in the last quarter. Pzena Investment Management LLC lifted its stake in Humana by 8.1% during the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after purchasing an additional 187,903 shares in the last quarter. Ontario Teachers Pension Plan Board boosted its position in shares of Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after buying an additional 71,910 shares during the period. Finally, Sanders Capital LLC grew its stake in shares of Humana by 1.0% in the third quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock valued at $370,060,000 after buying an additional 11,923 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Down 2.9 %

Shares of Humana stock opened at $294.18 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The company has a fifty day simple moving average of $275.44 and a 200-day simple moving average of $303.14. The stock has a market cap of $35.42 billion, a price-to-earnings ratio of 26.06, a PEG ratio of 2.15 and a beta of 0.55. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, equities analysts forecast that Humana Inc. will post 16.11 EPS for the current fiscal year.

Analyst Ratings Changes

HUM has been the topic of several research reports. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and increased their target price for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Morgan Stanley increased their price target on shares of Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Oppenheimer dropped their price objective on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a report on Thursday, October 3rd. Truist Financial increased their target price on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Finally, Leerink Partners downgraded shares of Humana from an “outperform” rating to a “market perform” rating and dropped their price target for the stock from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Humana has an average rating of “Hold” and a consensus target price of $297.68.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.